Article Sidebar

PDF
Date Published: 22/06/2022
Abstract Views: 285
Views PDF: 146
DOI: https://doi.org/10.51298/vmj.v515i1.2712
Issue
Vol. 515 No. 1 (2022)
Section
Các bài báo
How to Cite
Văn Dinh, N. ., Hồng Sơn, T. ., Ngọc Hà, H. ., & Hoàng Anh, V. . (2022). RESULTS OF SURGICAL TREATMENT OF COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA AT VIET DUC HOSPITAL PERIOD OF 2014 - 2019. Vietnam Medical Journal, 515(1). https://doi.org/10.51298/vmj.v515i1.2712

RESULTS OF SURGICAL TREATMENT OF COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA AT VIET DUC HOSPITAL PERIOD OF 2014 - 2019

Nguyễn Văn Dinh1,, Trịnh Hồng Sơn2, Hoàng Ngọc Hà3, Vũ Hoàng Anh4
1 Nam Dinh University of Nursing
2 Vietnam-Germany Friendship Hospital
3 Nam Dinh General Hospital
4 Trường Đại học Điều dưỡng Nam Định

Main Article Content

Abstract

Objectives of the study: To evaluate the results of surgical treatment of Combined hepatocellular-cholangiocarcinoma (CHC) at Viet Duc Hospital in the period 2014-2019. Subjects and methods of study: A retrospective study described more than 30 patients undergoing liver resection at Viet Duc hospital with CHC period from 2014 - 2019. Results: Early postoperative results: There were no cases of postoperative mortality, postoperative complications 53,3% (fluid accumulation was 36,7%, pleural effusion was 33,3%, liver failure after surgery was 3,3% and bleeding after surgery was 10%). Median hospital stay was 9,9 days. Long-term results showed that: The mean survival time after surgery up to the end of the study was 37,14±6,35 months, the survival rate of 13 months was 50%. Conclusion: Surgical treatment of mixed hepatobiliary tract hepatobiliary system brings positive results for patients with hepatocellular carcinoma.

Article Details

Keywords

Combined hepatocellular-cholangiocarcinoma, surgery

References

1. Nguyễn Quang Nghĩa (2012). Nghiên cứu áp dụng đo thể tích gan bằng chụp cắt lớp vi tính trong chỉ định, điều trị phẫu thuật ung thư gan nguyên phát. Luận án tiến sĩ y học, Học viện Quân Y, Hà Nội. 2012.
2. Trịnh Hồng Sơn, Lê Tư Hoàng (2001). Kết quả điều trị phẫu thuật ung thư gan nguyên phát tại bệnh viện Việt Đức giai đoạn 1992-1996. Tạp chí y học thực hành, 07: 42-46.
3. Lê Văn Thành (2013). Nghiên cứu chỉ định và kết quả phẫu thuật cắt gan kết hợp phương pháp Tôn Thất Tùng và Lortat Jacop điều trị ung thư biểu mô tế bào gan. Luận án tiến sĩ y học, Học viện Quân Y, Hà Nội. 2013.
4. D'Angelica M., Maddineni S., Fong Y., et al (2006). Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J Surg, 2006, 30(3): 410-418.
5. Ferrero A., Vigano L., Polastri R., et al (2007). Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study.World J Surg, 2007, 31(8): 1643-1651.
6. Jarnagin WR, Weber S, Tickoo SK, et al (2002). Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002;94:2040-2046.
7. Kim K.H, Lee S.G, Park E.H. et al (2009). Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Annals of surgical oncology. 2009;16:623-632.
8. Stavraka C, Rush H, Ross P (2018). Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions. Journal of Hepatocellular Carcinoma, 2018,11-21.